Translations:Antihypertensive drug/12/en: Difference between revisions

From Azupedia
Jump to navigation Jump to search
FuzzyBot (talk | contribs)
Importing a new version from external source
 
FuzzyBot (talk | contribs)
Importing a new version from external source
 
Line 11: Line 11:
* [[valsartan]]
* [[valsartan]]
* [[Fimasartan]]
* [[Fimasartan]]
In 2004, an article in the [[BMJ]] examined the evidence for and against the suggestion that angiotensin receptor blockers may increase the risk of [[myocardial infarction]] (heart attack). The matter was debated in 2006 in the medical journal of the [[American Heart Association]]. There is no consensus on whether ARBs have a tendency to increase MI, but there is also no substantive evidence to indicate that ARBs are able to reduce MI.{{citation needed|date=July 2019}}
In 2004, an article in the [[BMJ]] examined the evidence for and against the suggestion that angiotensin receptor blockers may increase the risk of [[myocardial infarction]] (heart attack). The matter was debated in 2006 in the medical journal of the [[American Heart Association]]. There is no consensus on whether ARBs have a tendency to increase MI, but there is also no substantive evidence to indicate that ARBs are able to reduce MI.

Latest revision as of 08:24, 4 November 2023

Information about message (contribute)
This message has no documentation. If you know where or how this message is used, you can help other translators by adding documentation to this message.
Message definition (Antihypertensive drug)
==Angiotensin II receptor antagonists==
[[File:Valsartan.svg|thumb|[[Valsartan]], an angiotensin II receptor antagonist]]
[[Angiotensin II receptor antagonist]]s work by [[receptor antagonist|antagonizing]] the activation of [[angiotensin receptor]]s.
* [[azilsartan]]
* [[candesartan]]
* [[eprosartan]]
* [[irbesartan]]
* [[losartan]]
* [[olmesartan]]
* [[telmisartan]]
* [[valsartan]]
* [[Fimasartan]]
In 2004, an article in the [[BMJ]] examined the evidence for and against the suggestion that angiotensin receptor blockers may increase the risk of [[myocardial infarction]] (heart attack). The matter was debated in 2006 in the medical journal of the [[American Heart Association]]. There is no consensus on whether ARBs have a tendency to increase MI, but there is also no substantive evidence to indicate that ARBs are able to reduce MI.

Angiotensin II receptor antagonists

Valsartan, an angiotensin II receptor antagonist

Angiotensin II receptor antagonists work by antagonizing the activation of angiotensin receptors.

In 2004, an article in the BMJ examined the evidence for and against the suggestion that angiotensin receptor blockers may increase the risk of myocardial infarction (heart attack). The matter was debated in 2006 in the medical journal of the American Heart Association. There is no consensus on whether ARBs have a tendency to increase MI, but there is also no substantive evidence to indicate that ARBs are able to reduce MI.